Aplio a550, Aplio a450, and Aplio a, Diagnostic Ultrasound System, Software V6.5

The Aplio a-series Diagnostic Ultrasound Systems, with Software V6.5, aim to enhance diagnostic capabilities across diverse clinical fields by integrating advanced multi-modal ultrasound imaging technologies and improved workflow solutions. This software iteration notably focuses on expanding quantitative imaging like Shear Wave Elastography and incorporating AI/ML for automated cardiac analysis, alongside specific enhancements for obstetric, liver, breast, and lung imaging.

The Aplio a550, Aplio a450, and Aplio a Diagnostic Ultrasound Systems, with Software V6.5, are mobile devices designed for visualizing human body structures and dynamic processes to aid in diagnosis across a wide spectrum of clinical applications. These applications include fetal, abdominal, intra-operative, pediatric, small organs, trans-vaginal, trans-rectal, cephalic, cardiac, vascular, transesophageal, musculo-skeletal, laparoscopic, and thoracic/pleural imaging. The systems utilize a variety of probes (flat linear, convex linear, sector array) operating at frequencies from approximately 2MHz to 20MHz and support numerous imaging modes such as B-mode, M-mode, Color Doppler, Pulsed Wave Doppler, Continuous Wave Doppler, Power Doppler, Shear Wave Elastography, Contrast Harmonic Imaging, and 3D/4D imaging. Software V6.5 introduces significant enhancements to existing functionalities, including improved network storage for raw data, secure DICOM data transfer via Tricefy Access, and expanded applications for Smart Body Mark (abdomen) and Shear Wave Elastography (SWE Hard). New presets for lung imaging, along with dedicated packages for liver and breast examinations, streamline workflow. Further refinements include SmartFetal2D for fetal heart analysis, MicroPure support in Reference mode, SWE integration in Smart Fusion, optimized OB 4D image quality, and improved OB measurement displays. The update also promotes the use of artificial intelligence and machine learning for automated contour tracing in cardiac functions like 2D Wall Motion Tracking and Auto Ejection Fraction, and expands marketing claims for liver analysis features (ATI, SWE) and MSK applications of SWE Hard based on published literature.

AI Regulatory Concerns

Powered by

Jev reads the full FDA letter and returns calibrated concern probabilities per regulatory category. These are AI estimates, not regulatory advice.

• Q1. How does the 'Full-assist function' utilizing AI/ML in 2D Wall Motion Tracking and Auto Ejection Fraction compare in accuracy and efficiency to manual or semi-automated methods for left ventricular assessment?; What specific improvements in the 'SWE Hard' feature expand its upper limit and range, and what is the clinical impact of these expansions, particularly in musculoskeletal (MSK) applications referenced by publications?; Could you elaborate on the technical optimization of ROI sampling and filter application that led to improved Obstetric (OB) 4D image quality in Software V6.5?; What are the specific existing features bundled into the 'Liver Package Basic' and 'Breast Package,' and how do these packages enhance diagnostic workflow or utility for these specific examinations?; Regarding the 'Lung Preset,' what specific imaging parameters are optimized, and how does this preset improve the visualization or diagnostic capability for thoracic/pleural conditions compared to general ultrasound settings?